Overview Lumos Labs has received FDA 510(k) clearance for LumosityRx, a prescription digital therapeutic (PDT) designed to improve attention in adults aged 22 to 55 with ADHD. Built o...
Browsing Tag: PrescriptionDigitalTherapeutics
1
2
3
digitalhealthX
Conversations Shaping Tomorrow's Healthcare